RecruitingPhase 4NCT06804980

DESIFOR-EXPAND (MHIF)

The DEterminig Statin Intolerance for Rosuvastatin Trial

Sponsor

Minneapolis Heart Institute Foundation

Enrollment

100 participants

Start Date

Feb 1, 2025

Study Type

INTERVENTIONAL

Conditions

Statin Statin Therapy Statin Adverse Reaction

Summary

The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients with prior statin intolerance

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Placebo and a drug called Rosuvastatin (Crestor) for people with statin, statin adverse reaction, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGRosuvastatin (Crestor)

The patient will take 3 28-day packs of placebo and 2 28-day packs of rosuvastatin. The order in which they take the placebo or rosuvastatin will be assigned at random.

DRUGPlacebo

The patient will take 3 28-day packs of placebo and 2 28-day packs of rosuvastatin. The order in which they take the placebo or rosuvastatin will be assigned at random.